Advertisement

Topics

Sartorius to Acquire Real-Time Live-Cell Analysis Pioneer and Leader Essen BioScience

04:41 EST 3 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Unique cell analysis platform for basic research and drug discovery has broad and expanding user base Acquisition to significantly enhance Sartorius’ Bioanalytics portfolio Sartori...

Other Sources for this Article

Sartorius
Petra Kirchhoff, Vice President of Corporate Communications
petra.kirchhoff@sartorius.com
Phone +49 (0)551.308.1686
Cell +49 (0)172.5603281
or
Essen BioScience
Jenna Brown, Feinstein Kean Healthcare
jenna.brown@fkhealth.com
Phone: +1.617.761.6724

NEXT ARTICLE

More From BioPortfolio on "Sartorius to Acquire Real-Time Live-Cell Analysis Pioneer and Leader Essen BioScience"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...